Top Markets
#1 DogBull DogBull +107.52%
#2 Siacoin Siacoin +51.89%
#3 ADO Protocol ADO Protocol +51.74%
#4 MarsCoin MarsCoin +44.04%
#5 The Bitcoin Bull The Bitcoin Bull +42.77%
#6 龙虾 (Lobster) 龙虾 (Lobster) +25.86%
#7 Ontology Gas Ontology Gas +22.70%
#8 UnifAI Network UnifAI Network +19.57%
#9 Arowana Arowana +19.45%
#10 Nockchain Nockchain +18.63%
Coin of the day
DogBull DogBull
설정
언어
한국어
통화
USD
테마
BioAge Labs Inc. BioAge Labs Inc.

BioAge Labs Inc.

BIOA
주식 순위 #15401
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops... BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.
주가
$9.50
시가총액
$357.67M
변동 (1일)
0.00%
변동 (1년)
92.70%
국가
US
거래 BioAge Labs Inc. (BIOA)

카테고리

Healthcare
BioAge Labs Inc. (BIOA)의 매출
Sep 2026 기준 매출 TTM: 0
BioAge Labs Inc.의 최신 재무 보고서에 따르면 회사의 현재 수익 (TTM)은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 0 대비 동일입니다. 수익은 상품이나 서비스를 판매하여 얻은 총 수입을 의미합니다. 수익과는 달리 비용이 차감되지 않습니다.
BioAge Labs Inc.의 수익 기록 (2026 ~ 2026)
매년 말 매출
연도 매출 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 매출
회사 매출 매출 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH